RenovoRx (Nasdaq:RNXT) announced that it priced an underwritten public offering of common stock worth proceeds of $12.1 ...
The FDA labeled a recall of integrated arterial catheters made by Medline Class I, the most serious kind of recall.
The Department of Robotics and Mechatronics Engineering research team at the Daegu Gyeongbuk Institute of Science and ...
The following is a summary of “Underutilized treatments for patients with refractory cancer pain: A qualitative study assessing the use of intrathecal drug delivery devices in the United Kingdom ...
RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a life sciences company developing novel targeted oncology therapies and commercializing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results